0000903423-19-000271.txt : 20190702
0000903423-19-000271.hdr.sgml : 20190702
20190702161323
ACCESSION NUMBER: 0000903423-19-000271
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190701
FILED AS OF DATE: 20190702
DATE AS OF CHANGE: 20190702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLAXOSMITHKLINE PLC
CENTRAL INDEX KEY: 0001131399
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: X0
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38940
FILM NUMBER: 19937462
BUSINESS ADDRESS:
STREET 1: 980 GREAT WEST ROAD
CITY: BRENTFORD MIDDLESEX
STATE: X0
ZIP: TW8 9GS
BUSINESS PHONE: 011442080475000
MAIL ADDRESS:
STREET 1: 980 GREAT WEST ROAD
CITY: BRENTFORD MIDDLESEX
STATE: X0
ZIP: TW8 9GS
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Morphic Holding, Inc.
CENTRAL INDEX KEY: 0001679363
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473878772
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 9787296480
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE A2
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Morphic Holding, LLC
DATE OF NAME CHANGE: 20160712
4
1
glaxo.xml
OWNERSHIP DOCUMENT
X0306
4
2019-07-01
0
0001679363
Morphic Holding, Inc.
MORF
0001131399
GLAXOSMITHKLINE PLC
980 GREAT WEST ROAD
BRENTFORD MIDDLESEX
X0
TW8 9GS
UNITED KINGDOM
1
0
0
0
Common Stock
2019-07-01
4
C
0
1469950
A
1469950
I
See Footnote
Common Stock
2019-07-01
4
C
0
830489
A
2300439
I
See Footnote
Common Stock
2019-07-01
4
P
0
333333
15
A
2633772
I
See Footnote
Series A preferred stock
2019-07-01
4
C
0
1469950
0
D
Common Stock
1469950
0
I
See Footnote
Series B preferred stock
2019-07-01
4
C
0
830489
0
D
Common Stock
830489
0
I
See Footnote
S.R. One, Limited acquired 333,333 common shares of the Issuer in connection with the Issuer's initial public offering.
Each share of the Issuer's Series A Preferred Stock automatically converted into one share of the Issuer's Common Stock on July 1, 2019 in connection with the closing of the Issuer's sale of its Common Stock in its initial public offering (the 'IPO") pursuant to a registration statement on Form S-1 (File No. 333-231837) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date..
Each share of the Issuer's Series B Preferred Stock automatically converted into one share of the Issuer's Common Stock on July 1, 2019 in connection with the closing of the Issuer's sale of its Common Stock in IPO pursuant to the Registration Statement, and had no expiration date.
The shares reported herein are held of record by S.R. One, Limited, an indirect,wholly-owned subsidiary of GlaxoSmithKline plc (the "Reporting Person").
/s/ Victoria Whyte
2019-07-02